Moderator: 3ne2nr Mods
Phone Surgeon wrote:What happens if you are asymptomatic and take the 3rd shot tho? Extreme side effects?
You are more likely to have more severe side effects after a prior vaccination or a COVID infection. An mRNA vaccine will typically cause more severe side effects, also.Phone Surgeon wrote:What happens if you are asymptomatic and take the 3rd shot tho? Extreme side effects?
adnj wrote:You are more likely to have more severe side effects after a prior vaccination or a COVID infection. An mRNA vaccine will typically cause more severe side effects, also.Phone Surgeon wrote:What happens if you are asymptomatic and take the 3rd shot tho? Extreme side effects?
De Dragon wrote:drchaos wrote:De Dragon wrote:paid_influencer wrote:redmanjp wrote:Parents of small children! watch out for Omicron!
https://www.sltrib.com/news/2022/01/21/utahs-covid/
I was going to post this same article, but I saw the photos in it and noped straight out
Nah, according to Hoover, Dr. Falsi and the anti vax brigade, iz only old and unfit getting Covid and deading
Too much fat clogging up your brain tubby!
Children still remain the rock bottom, lowest risk group for covid. So low that the studies for the vaccine couldn't find enough mortality data for their trial so they went with antibody response.
It's great that your lard filled obese rear end views are in direct opposition to Dr. Bratt.
If your shoelace dick had the ability to get an erection and produce children, you'd think differently if one of them died from Covid, you utter facking moron.
Phone Surgeon wrote:I think the majority of locals have sinopharm as their first two shots tho
paid_influencer wrote:wha madness i reading. AZ->Pfizer is the best option. go get it and thank the person giving it to you. it safe as far as we know.
AZ->pfizer performs better against the new variants than even 2x Pfizer. I have a graph attached from a preprint but I don't have the link right now. There's a theory that the heterogeneous vaccines create more broad b-cell differentiation, making it more 'future-proof' against new variants. that theory could be completely wrong, or right. Nobody knows, this is early days in the pandemic and all these vaccines are relatively new.
Heterologous Prime-Boost Vaccination
Shan Lu
Published online 2009 Jun 6.
Summary
An effective vaccine usually requires more than one time immunization in the form of prime-boost. Traditionally the same vaccines are given multiple times as homologous boosts. New findings suggested that prime-boost can be done with different types of vaccines containing the same antigens. In many cases such heterologous prime-boost can be more immunogenic than homologous prime-boost. Heterologous prime-boost represents a new way of immunization and will stimulate better understanding on the immunological basis of vaccines.
Introduction
It is not unusual that multiple immunizations are required for many vaccines to be successful. For pediatric population, up to five immunizations may be needed, as is the case for Diphtheria, Tetanus and Pertussis (DTP) vaccine, which is given three times during the first six months after birth, followed by a fourth dose in the second year of life, and a final boost between four and six years of age. Still, some of the vaccines need additional boosts even in adults who have already received the complete immunization series, for example, the Tetanus-diphtheria (Td) vaccine, for which a boost is recommended every 10 years throughout a person’s lifespan. While it is not entirely clear why some vaccines require more immunizations than others, it is well accepted that multiple immunizations (i.e. “prime-boost”) are critical for even the most successful vaccines. This principle applies to live attenuate vaccines (e.g., oral polio vaccine), inactivated vaccines (e.g., hepatitis A vaccine), recombinant protein subunit vaccines (e.g., hepatitis B vaccine) and polysaccharide vaccines (e.g., Haemophilus Influenzae type b vaccine). For these vaccines, the prime-boost is “homologous” because the same vaccines given in the earlier priming immunizations are used for subsequent boost immunizations.
Over the past decade, studies have shown that prime-boost immunizations can be given with unmatched vaccine delivery methods while using the same antigen, in a “heterologous” prime-boost format. The most interesting and unexpected finding is that, in many cases, heterologous prime-boost is more effective than the “homologous” prime-boost approach. The rapid progress of novel vaccination approaches, such as DNA vaccines and viral vector-based vaccines, has certainly further expanded the scope of heterologous prime-boost vaccination .
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743086/
matr1x wrote:I strongly suspect the doctors against ivermectin were either fake doctors or doctors who bribed their way to a medical degree and winged it
Speaking of which, we haven't heard from the 'chinee water' guy in a whilematr1x wrote:Sino has the least side effects. But that Pfizer......
Redman wrote:matr1x wrote:I strongly suspect the doctors against ivermectin were either fake doctors or doctors who bribed their way to a medical degree and winged it
Medical professionals were sanctioned if they voiced anything other than the narrative.
So many caves to the pressure.
adnj wrote:Japan's Kowa says ivermectin showed 'antiviral effect' against Omicron in research
By Reuters • 01/02/2022 - 11:20
TOKYO – Japanese trading and pharmaceutical company Kowa Co Ltd said on Monday anti-parasite drug ivermectin showed an “antiviral effect” against Omicron and other variants of coronavirus in joint non-clinical research.
The company did not provide further details.
The firm has been working with Kitasato University, a medical university in Tokyo, on testing the drug which is used to treat parasites in animals and humans, as a potential treatment for COVID-19.
https://www.euronews.com/2022/02/01/us- ... japan-kowa
adnj wrote:High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial
Available online 6 January 2022
ABSTRACT
High concentrations of ivermectin demonstrated antiviral activity against SARS-CoV-2 in vitro. The aim of this study was to assess the safety and efficacy of high-dose ivermectin in reducing viral load in individuals with early SARS-CoV-2 infection. This was a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial. Participants were adults recently diagnosed with asymptomatic/oligosymptomatic SARS-CoV-2 infection. Exclusion criteria were: pregnant or lactating women; CNS disease; dialysis; severe medical condition with prognosis <6 months; warfarin treatment; and antiviral/chloroquine phosphate/hydroxychloroquine treatment. Participants were assigned (ratio 1:1:1) according to a randomised permuted block procedure to one of the following arms: placebo (arm A); single-dose ivermectin 600 μg/kg plus placebo for 5 days (arm B); and single-dose ivermectin 1200 μg/kg for 5 days (arm C). Primary outcomes were serious adverse drug reactions (SADRs) and change in viral load at Day 7. From 31 July 2020 to 26 May 2021, 32 participants were randomised to arm A, 29 to arm B and 32 to arm C. Recruitment was stopped on 10 June because of a dramatic drop in cases. The safety analysis included 89 participants and the change in viral load was calculated in 87 participants. No SADRs were registered. Mean (S.D.) log10 viral load reduction was 2.9 (1.6) in arm C, 2.5 (2.2) in arm B and 2.0 (2.1) in arm A, with no significant differences (P = 0.099 and 0.122 for C vs. A and B vs. A, respectively). High-dose ivermectin was safe but did not show efficacy to reduce viral load.
https://www.sciencedirect.com/science/a ... 7921013571
YupKenjo wrote:adnj wrote:High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial
Available online 6 January 2022
ABSTRACT
High concentrations of ivermectin demonstrated antiviral activity against SARS-CoV-2 in vitro. The aim of this study was to assess the safety and efficacy of high-dose ivermectin in reducing viral load in individuals with early SARS-CoV-2 infection. This was a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial. Participants were adults recently diagnosed with asymptomatic/oligosymptomatic SARS-CoV-2 infection. Exclusion criteria were: pregnant or lactating women; CNS disease; dialysis; severe medical condition with prognosis <6 months; warfarin treatment; and antiviral/chloroquine phosphate/hydroxychloroquine treatment. Participants were assigned (ratio 1:1:1) according to a randomised permuted block procedure to one of the following arms: placebo (arm A); single-dose ivermectin 600 μg/kg plus placebo for 5 days (arm B); and single-dose ivermectin 1200 μg/kg for 5 days (arm C). Primary outcomes were serious adverse drug reactions (SADRs) and change in viral load at Day 7. From 31 July 2020 to 26 May 2021, 32 participants were randomised to arm A, 29 to arm B and 32 to arm C. Recruitment was stopped on 10 June because of a dramatic drop in cases. The safety analysis included 89 participants and the change in viral load was calculated in 87 participants. No SADRs were registered. Mean (S.D.) log10 viral load reduction was 2.9 (1.6) in arm C, 2.5 (2.2) in arm B and 2.0 (2.1) in arm A, with no significant differences (P = 0.099 and 0.122 for C vs. A and B vs. A, respectively). High-dose ivermectin was safe but did not show efficacy to reduce viral load.
https://www.sciencedirect.com/science/a ... 7921013571
Wait so finally some studies coming out ? Wasn’t the narrative that it had insufficient evidence all along ?
Redman wrote:There is ample evidence of successful usage of ivermectin globally.
And multiple studies.
There are.protocols online videos of doctors who have successfully used the drug in their practice.
You have to pick your poison... literally and figuratively.
drchaos wrote:The Narrative is collapsing ...
single-dose ivermectin 1200 μg/kg for 5 days...
High-dose ivermectin was safe but did not show efficacy to reduce viral load.
https://www.sciencedirect.com/science/a ... 7921013571
Return to “Ole talk and more Ole talk”
Users browsing this forum: Duane 3NE 2NR and 94 guests